GENE ONLINE|News &
Opinion
Blog

Sangeeta Chakraborty

WRITTEN BY Sangeeta Chakraborty

Thermo Fischer Snags Novasep’s Low-Cost CMO for $879 Million
2021-01-17
Hoping to Boost Revenue Growth, Gilead Acquires MYR in a $1.4 B Deal
2020-12-13
ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
2020-12-07
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
Russian Vaccine Makers Nudge AstraZeneca to Combine COVID-19 Vaccine, AZD1222 with Sputnik V
2020-11-28
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
Novartis Secures Exclusive Rights of Mesoblast’s Cell Therapy for COVID-19 Related ARDS
2020-11-21
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
Insilico’s AI Pipeline for Drug Discovery To Grow with New Partnership
2020-11-11
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
Exact Sciences Looks to Thrive in Blood-Based, Early Cancer Detection Space with Two New Buyouts
2020-10-29
Lilly’s Coronavirus Antibody Treatment Hits Pause Button Over Potential Safety Issues
2020-10-16
Novartis’ Kymriah Headed Towards Third Approval for Follicular Lymphoma
2020-08-06
1 2
Scroll to Top